Xeris Biopharma Holdings, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 2.87x
Net debt / equity: -5.72x
Debt / assets: 0.10x
Debt / EBITDA: 0.81x
Net debt / EBITDA: -1.61x

Liquidity & coverage

Current ratio: 2.12x
Quick ratio: 1.50x
Cash ratio: 0.94x
Interest coverage: 1.25x
EBITDA / interest: 1.61x
Working capital: $133.1M

Cash & dividend

FCF / debt: 1.27x
Cash flow / debt: 1.30x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.